Accelerate Diagnostics, Inc. today announced that it will have 3 data presentations from its Improving Outcomes and Antibiotic Stewardship (IOAS) Study at the European Congress of Clinical Microbiology & Infectious Diseases to be held July 9–12, 2021.
Accelerate Diagnostics, Inc. and BioCheck, Inc., a privately-held San Francisco-based company focused on in vitro diagnostics, announced that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for the ...